首页> 美国卫生研究院文献>Annals of Transplantation >Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial

【2h】

Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial

机译：曾经每日LCP-tacrolimus的疗效和安全性与成人西班牙稳定肾移植受者的两次直接释放的曲粒剂：来自第3阶段试验的子组分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Annals of Transplantation
作者
Arman Faravardeh; Sanjeev Akkina; Rafael Villicana; Giselle Guerra; Misbah A. Moten; Ulf Meier-Kriesche; Daniel R. Stevens; Samir J. Patel; Suphamai Bunnapradist;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类外科学;移植;
关键词
Glomerular Filtration Rate; Graft Rejection; Kidney Transplantation; Safety; Tacrolimus;

机译：肾小球过滤速率;移植物排斥;肾移植;安全;他克莫司;

相似文献

外文文献

1. LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups [J] . Bunnapradist Suphamai, Rostaing Lionel, Alloway Rita R., Transplant international : . 2016,第5期

机译：LCPT每日一次他克莫司缓释片与每日两次胶囊剂：对重要的从头和稳定的肾脏移植受者亚组的两项3期试验进行汇总分析
2. LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups [J] . Bunnapradist Suphamai, Rostaing Lionel, Alloway Rita R., Transplant international : . 2016,第5期

机译：LCPT曾经每日延长释放的Tacrolimus片剂与两次每日胶囊：在重要的de Novo和稳定的肾移植受体亚组中的两阶段3试验的汇总分析
3. Safety and efficacy of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Graceptor) in stable kidney transplant recipients [J] . NakamuraY., HamaK., KatayamaH., Transplantation Proceedings . 2012,第1期

机译：在稳定的肾脏移植受者中从每日两次他克莫司（Prograf）转换为每天一次长时间释放他克莫司（Graceptor）的安全性和有效性
4. Mycophenolic acid versus azathioprine in primary immunosuppression for kidney transplant recipients - Systematic review, meta-analysis, and meta-regression. [D] . Wagner, Martin. 2009

机译：麦考酚酸与硫唑嘌呤在肾移植受者初次免疫抑制中的作用-系统评价，荟萃分析和荟萃回归。
5. Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial [O] . Barbara Suwelack, Suphamai Bunnapradist, Ulf Meier-Kriesche, 2020

机译：Novo肾移植受者的浓度/剂量比接受LCP-Tacolimus或立即释放的Tacrolimus的影响：HOC分析3期临床试验
6. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial [O] . Rostaing Lionel, Bunnapradist Suphamai, Grinyó Josep M., 2016

机译：新的每日一次延长发布的他克莫司与两次每天他克莫司在从头肾移植受者中的研究：第3期，双盲，随机试验的两年结果

Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial

著录项

相似文献

相关主题

期刊订阅